Articles By Estel Grace Masangkay

  1. GSK And Avalon Launch 2 Drug Firm Startups 9/24/2014

    GlaxoSmithKline and Avalon Ventures announced the launch of two new early-stage life science companies named Silarus Therapeutics and Thyritope Biosciences. Both companies will be based in San Diego and will each receive $10 million in initial financing.

  2. CASI Signs China Licensing Deal With Spectrum For 3 Cancer Drugs 9/23/2014

    CASI Pharmaceuticals and Spectrum Pharmaceuticals (SPPI) announced the signing of a license agreement that gives CASI exclusive rights to develop three cancer drugs from Spectrum and market them in China, including Macau, Hong Kong, and Taiwan.

  3. PCI Acquires Biotec, Expands Global Clinical Services 9/22/2014

    Packaging Coordinators, Inc. (PCI) announced its acquisition of clinical services provider Biotec Services. PCI says the acquisition expands its presence in the U.K./EU territories to support global drug clinical trials and clinical trial suppliers.

  4. Merck Serono And Sutro Link Arms To Develop ADCs Against Cancer 9/19/2014

    Merck Serono, Merck KGaA’s biopharmaceutical division, announced its collaboration with Sutro Biopharma to develop antibody drug conjugates (ADCs) and expand Merck Serono’s oncology pipeline.

  5. Denovo Acquires Lilly's Oncology Drug Enzastaurin 9/19/2014

    Denovo Biopharma announced its acquisition of Eli Lilly’s late-stage oncology candidate enzastaurin. The company has bought worldwide rights to develop, produce, and market enzastaurin, along with the intellectual property rights and other data.

  6. Merck And Lupin Enter Partnership In Emerging Markets 9/18/2014

    Merck’s biopharmaceutical division Merck Serono announced that it has signed into a long-term collaboration with Indian pharmaceutical firm Lupin for the expansion of Merck’s General Medicines portfolio in emerging markets.

  7. Court Says PhRMA Must File New Suit Against 340B Interpretive Rule 9/17/2014

    The Washington D.C. District Court ruled that the Pharmaceutical Research and Manufacturers of America (PhRMA) needs to file a separate complaint in order to challenge a new interpretive rule covering orphan drugs in the 340B orphan drug rule.

  8. Akashi Acquires Rights To Neuromuscular Disease Drug 9/17/2014

    Clinical stage biopharmaceutical company Akashi Therapeutics announced that it has acquired worldwide rights to Tonus Therapeutics’ GsMTx-4.

  9. Counterfeits Of Roche's MabThera Discovered In Germany 9/16/2014

    Last week, counterfeit vials of Roche’s MabThera were discovered in Germany. This is the second time this year that Roche’s drugs have been targeted by counterfeiters, Reuters reports.

  10. SRI And Nobelpharma Collaborate On Endometriosis Drug 9/12/2014

    Independent nonprofit research institute SRI International announced that it has entered into a licensing agreement with Japanese pharmaceutical firm NobelPharma for the development of SR16234, a drug candidate for the treatment of endometriosis.